Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy

Anna M Asp1, Carin Wallquist, Anette Rickenlund

  • 1Department of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Insights

Chronic kidney disease (CKD) is linked to early cardiac abnormalities, including altered systolic and diastolic function and increased left ventricular hypertrophy (LVH). These changes suggest a precursor to premature cardiac morbidity in CKD patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Cardiorenal Medicine

Background:

  • Left ventricular (LV) hypertrophy (LVH) and reduced LV function are associated with poor prognosis in chronic kidney disease (CKD).
  • Investigating cardiac abnormalities in mild-to-moderate CKD is crucial for understanding disease progression.

Purpose of the Study:

  • To determine if mild-to-moderate CKD is associated with cardiac abnormalities.
  • To assess systolic and diastolic myocardial function in CKD patients.

Main Methods:

  • Echocardiography with tissue Doppler imaging in 103 CKD patients (stages 2-5) and 53 controls.
  • Measurement of systolic (s') and diastolic myocardial velocities (e'), and transmitral flow velocity (E).
  • Calculation of the E/e' ratio to assess diastolic function.

Main Results:

  • CKD patients exhibited significantly higher mean E/e' ratios compared to controls, indicating impaired diastolic function.
  • Lower longitudinal systolic function (atrio-ventricular plane displacement and s') was observed in CKD groups.
  • Increased prevalence of LVH was found in CKD patients (30-37%) versus controls (13%).

Conclusions:

  • Mild-to-moderate CKD is associated with significant alterations in systolic and diastolic myocardial function.
  • Cardiac involvement begins early in the course of CKD.
  • These early cardiac changes may predispose CKD patients to premature cardiac morbidity.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
587
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
682